GlassScriptPhysician profile
Nicholas Hallman
NPI 1194429647
$2,493.82
in general payments reported to CMS, 2019-2025
10 companies · $1,284 in 2025
The $1,284 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $245 · 2024: $965 · 2025: $1,284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,394 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,393.83 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $522.50 | 2024-2025 | Acthar |
| Johnson & Johnson Surgical Vision, INC. | $365.43 | 2024-2025 | Veritas Vision System, Tecnis Iol |
| Apellis Pharmaceuticals, INC. | $365.19 | 2023-2025 | Syfovre |
| Abbvie INC. | $346.45 | 2024-2025 | |
| Alcon Vision LLC | $344.72 | 2023-2025 | Hydrus Microstent, Tryptyr, Centurion |
| Ani Pharmaceuticals, INC. | $242.46 | 2024-2025 | Purified Cortrophin Gel, Yutiq |
| Sight Sciences, INC. | $138.20 | 2024 | Omni Surgical System |
| Biotissue Holdings INC. | $117.23 | 2024 | |
| Carl Zeiss Meditec USA, INC. | $28.13 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $23.51 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Hallman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.